AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+22.05%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.9B
AUM Growth
+$1.9B
(+39%)
Cap. Flow
+$44.9M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
30.44%
Holding
97
New
19
Increased
29
Reduced
22
Closed
18
Top Buys
| 1 |
Medtronic
MDT
|
$54.3M |
| 2 |
Biogen
BIIB
|
$42.3M |
| 3 |
UnitedHealth
UNH
|
$33M |
| 4 |
Lantheus
LNTH
|
$32.9M |
| 5 |
AutoZone
AZO
|
$31.6M |
Top Sells
| 1 |
VXRT
Vaxart
VXRT
|
$222M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$40.6M |
| 3 |
Deckers Outdoor
DECK
|
$30.5M |
| 4 |
Amazon
AMZN
|
$29M |
| 5 |
Dollar Tree
DLTR
|
$22.4M |
Sector Composition
| 1 | Healthcare | 54.5% |
| 2 | Consumer Discretionary | 18.97% |
| 3 | Consumer Staples | 11.9% |
| 4 | Technology | 6.34% |
| 5 | Industrials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $77.8M | 3.41% | 29,914,285 +1,753,680 | +6% | +$4.56M |
|
|
2
UnitedHealth
UNH
$281B
| $59M | 2.59% | 200,000 +112,000 | +127% | +$33M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $58.8M | 2.58% | 1,000,000 +352,000 | +54% | +$20.7M |
|
|
4
Biogen
BIIB
$19.4B
| $57.8M | 2.53% | 216,000 +158,000 | +272% | +$42.3M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $56.1M | 2.46% | 500,000 +72,000 | +17% | +$8.08M |
|
6
Vanda Pharmaceuticals
VNDA
$279M
| $54.9M | 2.41% | 4,800,000 +232,000 | +5% | +$2.65M |
|
7
Energizer
ENR
$1.88B
| $54.5M | 2.39% | 1,148,000 +276,000 | +32% | +$13.1M |
|
|
8
Medtronic
MDT
$119B
| $54.3M | 2.38% | +592,000 | New | +$54.3M |
|
9
Supernus Pharmaceuticals
SUPN
$2.53B
| $52.4M | 2.3% | 2,208,000 -792,000 | -26% | -$18.8M |
|
|
10
Lantheus
LNTH
$3.73B
| $51.8M | 2.27% | 3,624,000 +2,300,000 | +174% | +$32.9M |
|
11
Incyte
INCY
$16.5B
| $45.3M | 1.99% | 436,000 -92,000 | -17% | -$9.57M |
|
12
Central Garden & Pet Class A
CENTA
$2.08B
| $44.7M | 1.96% | 1,324,000 -176,000 | -12% | -$5.95M |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $42.4M | 1.86% | 68,000 +4,000 | +6% | +$2.49M |
|
14
Five Below
FIVE
$8B
| $40.4M | 1.77% | 378,005 +43,411 | +13% | +$4.64M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $36.6M | 1.6% | 500,000 -556,000 | -53% | -$40.6M |
|
16
Dropbox
DBX
$7.84B
| $35.4M | 1.55% | 1,624,000 -68,000 | -4% | -$1.48M |
|
17
Dollar General
DG
$23.9B
| $35.3M | 1.55% | 185,421 +19,788 | +12% | +$3.77M |
|
18
Ross Stores
ROST
$48.1B
| $34.9M | 1.53% | 409,344 +291,630 | +248% | +$24.9M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $34.7M | 1.52% | 568,000 -80,000 | -12% | -$4.88M |
|
|
20
Amazon
AMZN
$2.44T
| $34.5M | 1.51% | 12,500 -10,500 | -46% | -$29M |
|
21
AptarGroup
ATR
$9.18B
| $32.3M | 1.41% | 288,000 +138,000 | +92% | +$15.5M |
|
|
22
AutoZone
AZO
$70.2B
| $31.6M | 1.39% | +28,000 | New | +$31.6M |
|
|
AMAG
23
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $31.5M | 1.38% | 4,120,000 | – | – |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $31.1M | 1.36% | 272,000 -40,000 | -13% | -$4.57M |
|
25
Best Buy
BBY
$15.6B
| $29M | 1.27% | +331,919 | New | +$29M |
|